With 411 patents held between 2002 and 2022, L'Oreal SA holds the most number of Nanomedicine patents in the Consumer sector in the Europe region.
The second largest number of patents were held by BASF SE with 82 Nanomedicine patents. The third largest number of patents were held by The Procter & Gamble Co with 59 Nanomedicine patents. The fourth largest number of patents were held by Henkel AG & Co KGaA with 57 Nanomedicine patents. The fifth largest number of patents were held by maxingvest ag with 49 Nanomedicine patents.
The top five patents holders, i.e., L'Oreal SA, BASF SE, The Procter & Gamble Co, Henkel AG & Co KGaA, and maxingvest ag, together held 658 Nanomedicine patents during the period.
Switzerland
France
United States of America
United States of America
Brazil
South Korea
United Kingdom
Belgium
China
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward